SAN FRANCISCO, June 30, 2011 /PRNewswire/ -- Merriman Capital,
Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (NASDAQ:
MERR), today announced that it will serve as the Principal American
Liaison (PAL) for Medifocus, Inc. (OTCQX: MDFZF; TSX.V: MFS) as it
begins trading on OTCQX®.
(Logo:
http://photos.prnewswire.com/prnh/20100914/SF64919LOGO)
Medifocus owns a patented adaptive phased array (APA) microwave
focusing technology platform that can precisely target and
concentrate microwave energy to destroy cancer tumors without
damaging healthy tissue when used alone or in conjunction with
chemotherapy or radiation. The Company announced today that
it is now trading on the OTC market's highest tier, OTCQX.
OTCQX distinguishes the best companies traded over-the-counter
(OTC) from more than 9,000 securities traded on the OTCBB and OTC
Link that are not required to meet any financial standards or
undergo a qualitative review.
Spencer Grimes, Merriman Capital
Managing Director, said: "Medifocus has its main operations in
the United States and will be
starting a pivotal breast cancer treatment study in this country,
so it is natural for the Company to increase its exposure to U.S.
investors. We are proud to partner with Medifocus in this
effort, and joining OTCQX is a great first step."
Dr. Augustine Y. Cheung, CEO of
Medifocus, commented: "Having our shares trade on OTCQX, in
addition to our Canadian presence on the TSX.V, provides Medifocus
with an excellent method of accessing the U.S. capital markets,
while providing U.S. investors with the accessibility, transparency
and liquidity necessary for potential shareholders to feel
comfortable when making an investment decision. The U.S.
breast cancer marketplace is 10 times the size of Canada's; thus we believe we will be able to
attract an increased number of investors and greater interest from
the U.S. capital markets."
About Merriman Capital, Inc.
Merriman Capital, Inc. is a full-service investment banking firm
that provides investment banking, sales and trading, and equity
research services to corporate and institutional clients and high
net worth investors. Merriman Capital, Inc. is a wholly owned
subsidiary of Merriman Holdings, Inc., which is listed on the
NASDAQ Stock Market and trades under the symbol "MERR."
Merriman specializes in four growth sector industries:
Technology, Telecom, Consumer, Media & Internet and CleanTech
Infrastructure. For more information, please go to
http://www.merrimanco.com/.
Merriman Capital, Inc. is a registered broker-dealer and member
of The Financial Industry Regulatory Authority (FINRA)
http://www.finra.org and the Securities Investor Protection
Corporation (SIPC) http://www.sipc.org/contact.cfm.
About Medifocus, Inc.
Medifocus, Inc. (OTCQX: MDFZF; TSX.V: MFS) trades in
the United States on OTCQX under
the symbol "MDFZF." Medifocus owns a patented adaptive phased
array (APA) microwave focusing technology platform which can
precisely target and concentrate microwave energy to destroy cancer
tumors without damaging healthy tissue when used alone or in
conjunction with chemotherapy or radiation. The ability to
target tumors with a precision controlled dose of heat can be used
to destroy tumors at higher temperatures, to treat tumors in
combination with chemotherapy and/or radiation at moderate
temperatures for increased effectiveness over those treatments
alone, and to activate temperature sensitive drugs for tumor
targeted localized drug delivery. Medifocus has completed the
development of a dedicated commercial cancer treatment system for
the treatment of breast cancer and is actively pursuing development
of additional systems for other cancers. Website:
www.medifocusinc.com.
About OTCQX
The OTCQX marketplace is the premier tier of the U.S. OTC
market. Investor-focused companies use the quality-controlled
OTCQX platform to offer investors transparent trading, superior
information, and easy access through their regulated U.S.
broker-dealers. The innovative OTCQX platform offers
companies and their shareholders a level of marketplace services
formerly available only on a U.S. stock exchange. For more
information and to view a full list of OTCQX companies, visit
www.otcqx.com.
Note to Investors
This press release contains certain forward-looking
statements based on our current expectations, forecasts and
assumptions that involve risks and uncertainties. This release does
not constitute an offer to sell or a solicitation of offers to buy
any securities of the Company. Forward-looking statements in this
release are based on information available to us as of the date
hereof. Our actual results may differ materially from those stated
or implied in such forward-looking statements, due to risks and
uncertainties associated with our business, which include the risk
factors disclosed in our Form 10-K/A filed on April 28, 2011. Forward-looking statements
include statements regarding our expectations, beliefs, intentions
or strategies regarding the future and can be identified by
forward-looking words such as "anticipate," " believe," "could,"
"estimate," "expect," "intend," "may," "should," and "would" or
similar words. We assume no obligation to update the information
included in this press release, whether as a result of new
information, future events or otherwise. The Form 10-K/A filed on
April 28, 2011, together with this
press release and the financial information contained herein, are
available on our website, www.merrimanco.com. Please click on
"Investor Relations."
SOURCE Merriman Holdings, Inc.